Homolactones of Androst-5-ene Derivatives
1389
(C-4′, Ph ); 127.0 an d 128.3 (C-2′, C-3′, C-5′, C-6′, Ph ); 140.9 (C-1′, Ph ); 142.4 (C-5). For
C
25H33NO2·0.5H2O (388.5) calculated: 77.28% C, 8.82% H; foun d: 77.47% C, 8.51% H.
(17R)-3β-Acetoxy-17-hydroxy-17-phenyl-16,17-secoandrost-5-ene-16-nitrile (9). Wh ite crystals
(82%, m .p. 204 °C after crystallization from MeOH). IR: 3700–3120, 2240, 1730, 1240, 1040,
700. 1H NMR (aceton e-d6): 0.93 s, 3 H (H-19); 1.02 s, 3 H (H-18); 2.04 s, 3 H (CH3, Ac);
4.39 d, 1 H, J = 3.6 (H-17); 4.51 m , 1 H (H-3); 4.72 d, 1 H, J = 3.6 (OH-17); 5.42 m , 1 H
(H-6); 7.23–7.40 m , 5 H (Ph ). 13C NMR (aceton e-d6): 16.8, 18.6, 19.5, 20.2 (CH3, Ac); 27.4,
31.2, 31.9, 32.5, 36.4, 36.6, 37.6, 40.6, 42.2, 49.0, 73.2 an d 78.2 (C-3, C-17); 119.8 (CN);
121.5, 126.8 (C-4′, Ph ); 127.1 (C-3′, C-5′, Ph ); 128.2 (C-2′, C-6′, Ph ); 139.5 (C-1′, Ph ); 142.1
(C-5); 169.4 (CO, Ac). For C27H35NO3·0.25H2O (426.1) calculated: 76.11% C, 8.40% H;
foun d: 76.02% C, 8.37% H.
(17S)-17-Benzyl-3β,17-dihydroxy-16,17-secoandrost-5-ene-16-nitrile (10). Colorless oil (83%).
IR: 3700–3150, 2250, 1070, 1040, 720. 1H NMR (CDCl3): 1.05 s, 3 H (H-19); 1.11 s, 3 H
(H-18); 2.50 dd, 1 H, Jgem = 12.5, J17,Ha = 9.0 (Ha, CH2Ph ); 2.91 d, 1 H, Jgem = 12.5 (Hb,
CH2Ph ); 3.54 m , 1 H (H-3); 3.59 d, 1 H, J17,Ha = 9.0 (H-17); 5.38 m , 1 H (H-6); 7.20–7.38 m ,
5 H (ArH). 13C NMR (DMSO-d6): 14.8, 17.5 (C-18); 19.2 (C-19); 20.1, 31.5, 32.0, 32.1, 33.2,
36.7, 36.9, 37.9, 40.1, 41.9, 42.7, 49.0, 71.6 (C-3); 78.0 (C-17); 119.8 (CN); 120.6, 126.8
(C-4′, Bn ); 128.9 (C-3′, C-5′, Bn ); 129.3 (C-2′, C-6′, Bn ); 139.1 (C-1′, Bn ); 140.4 (C-5).
(17S)-3β-Acetoxy-17-benzyl-17-hydroxy-16,17-secoandrost-5-ene-16-nitrile (11). Colorless oil
(90%). IR: 3600–3300, 2230, 1720, 1245, 1030, 730, 690. 1H NMR (CDCl3): 1.06 s, 3 H
(H-19); 1.11 s, 3 H (H-18); 2.04 s, 3 H (CH3, Ac); 2.50 dd, 1 H, Jgem = 12.5, J17,Ha = 9.0 (Ha,
CH2Ph ); 2.91 d, 1 H, Jgem = 12.5 (Hb, CH2Ph ); 3.59 d, 1 H, J17,Ha = 9.0 (H-17); 4.61 m , 1 H
(H-3); 5.39 m , 1 H (H-6); 7.20–7.39 m , 5 H (ArH). 13C NMR (DMSO-d6): 14.7, 17.5, 19.1,
20.0, 21.4, 27.6, 31.5, 31.8, 31.9, 36.6, 36.8, 37.9, 40.1, 42.6, 48.9, 73.7, 78.0, 119.8 (CN);
121.5, 126.8, 128.9, 129.3, 139.1, 170.5 (CO, Ac).
3β-Hydroxy-17aα-ph en yl-17-oxa-17a-h om oan drost-5-en -16-on e (12)
A) Com poun d 8 (0.05 g, 0.13 m m ol) was dissolved in eth ylen e glycol (3 m l) an d KOH
(0.295 g, 5.28 m m ol) was added. Th e reaction m ixture was refluxed for 4 h an d th en poured
in to water (6 m l), acidified with HCl (1:1) to pH 1 an d extracted with CH2Cl2 (5 × 20 m l).
Th e extract was dried an d th e solven t rem oved un der reduced pressure, wh ich resulted in
crude product 12 (0.075 g) as yellow oil. Th e product was ch rom atograph ed on a silica gel
colum n (8 g, CH2Cl2–MeOH 70:1) givin g com poun d 12 (0.043 g, 77%; m .p. 216 °C after
recrystallization from CH2Cl2–h exan e 2:1) as wh ite crystals.
B) By th e sam e procedure as in A), com poun d 9 (0.05 g, 0.11 m m ol) yielded th e crude
product 12 (0.062 g) in th e form of yellow oil. Colum n ch rom atograph y on silica gel (7 g,
ben zen e–EtOAc 5:1), afforded com poun d 12 (0.043 g, 91%) as wh ite crystals. IR: 3700–3100,
1730, 1230, 1190, 1030, 760, 700. 1H NMR (CDCl3): 0.97 s, 3 H (H-19); 1.24 s, 3 H (H-18);
3.44 m , 1 H (H-3); 5.14 s, 1 H (H-17); 5.30 m , 1 H (H-6); 7.04–7.38 m , 5 H (ArH). 13C NMR
(CDCl3): 18.2, 19.3, 19.5, 30.5, 31.3, 32.3, 33.0, 34.6, 35.4, 36.4, 36.6, 37.5, 41.9, 48.1, 71.5
(C-3); 91.5 (C-17); 120.4 (C-6); 127.4 an d 128.0 (C-2′, C-3′, C-5′, C-6′, Ph ); 128.1 (C-4′);
136.8 (C-1′, Ph ); 140.5 (C-5); 171.0 (C-16). For C25H32O3 (380.5) calculated: 78.91% C,
8.48% H; foun d: 79.23% C, 8.92% H.
Collect. Czech. Chem. Commun. (Vol. 70) (2005)